On February 20, a groundbreaking clinical trial led by Academician Jun Ma, Prof. Ying Sun and Prof. Linglong Tang from Sun Yat-sen University Cancer Center (SYSUCC), was published in CA: A Cancer Journal for Clinicians (Impact Factor: 503.1), the world’s most influential oncology journal.
The trial, a phase Ⅲ study on reduced-volume vs. conventional radiotherapy after induction chemotherapy in nasopharyngeal carcinoma (NPC), found that targeting only the post-chemotherapy tumor volume maintained excellent locoregional control, reduced toxicity, and improved quality of life for patients.
This research represents an important advancement in NPC treatment and a milestone for CA, which marks the first original clinical trial research published in the journal since its inception.
Link to the article: https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21881
